LITS Share Price Performance
US$2.45
-0.32 (-11.55%)
Price US$2.45
Share PriceUS$2.45
Lite Strategy, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
LITS Community Narratives
There are no narratives available yet.
Recent LITS News & Updates
Lite Strategy, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.45
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Lite Strategy, Inc. Competitors
Snowflake Analysis
About LITS
- Founded
- 2000
- Employees
- 4
- CEO
- WebsiteView website
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
U.S. Market Performance
- 7 Days: 1.1%
- 3 Months: 8.9%
- 1 Year: 18.9%
- Year to Date: 15.1%
Over the last 7 days, the market has risen 1.1%, driven by gains of 1.9% in the Information Technology sector. The market is up 19% over the last 12 months. Earnings are forecast to grow by 15% annually. Market details ›